From the multivariant analysis, some PLS models were developed using the plasma biomarkers as predictor variables (Aβ42, Aβ40, t-Tau, p-Tau181, NfL, TDP-43), and the participants group as a response variable, to detect early and specific AD. This evidence concerns the gene NEFL and Alzheimer disease.